Author:
Taur Jan-Shiang,Zhao Chunsheng,Darna Mahesh,Chang Yang,Lu Yang,Mao Jinzhe,Cai Wendy,Ren Ke,Braddy April C.
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Tukey RH, Strassburg CP. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol. 2000;40:581–616.
2. US Food and Drug Administration: Guidance for industry: safety testing of drug metabolites (2020). https://www.fda.gov/regulatory-information/search-fda-guidance-documents/safety-testing-drug-metabolites. Accessed 21 Sep 2022.
3. Frances B, Gout R, Campistron G, Panconi E, Cros J. Morphine-6-glucuronide is more mu-selective and potent in analgesic tests than morphine. Prog Clin Biol Res. 1990;328:477–80.
4. van Heek M, Farley C, Compton DS, Hoos L, Alton KB, Sybertz EJ, Davis HR Jr. Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663. Br J Pharmacol. 2000;129(8):1748–54.
5. Faed EM. Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metab Rev. 1984;15(5-6):1213–49.